Marina Chiara Garassino to Registries
This is a "connection" page, showing publications Marina Chiara Garassino has written about Registries.
Connection Strength
0.999
-
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020 07; 21(7):914-922.
Score: 0.501
-
COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response. JAMA Oncol. 2021 12 01; 7(12):1882-1890.
Score: 0.139
-
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration. Cancer Cell. 2020 06 08; 37(6):742-745.
Score: 0.125
-
Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study. Thorac Cancer. 2020 06; 11(6):1661-1669.
Score: 0.124
-
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1=50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. J Immunother Cancer. 2025 Feb 04; 13(2).
Score: 0.043
-
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. J Thorac Oncol. 2022 05; 17(5):661-674.
Score: 0.035
-
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience. Cancer Cell. 2020 11 09; 38(5):602-604.
Score: 0.032